BML, Inc. (TYO:4694)
2,833.00
+1.00 (0.04%)
Mar 11, 2025, 3:30 PM JST
BML, Inc. Revenue
BML, Inc. had revenue of 37.21B JPY in the quarter ending December 31, 2024, with 5.98% growth. This brings the company's revenue in the last twelve months to 141.33B, up 0.42% year-over-year. In the fiscal year ending March 31, 2024, BML, Inc. had annual revenue of 137.96B, down -13.48%.
Revenue (ttm)
141.33B
Revenue Growth
+0.42%
P/S Ratio
0.79
Revenue / Employee
31.32M
Employees
4,513
Market Cap
111.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 137.96B | -21.50B | -13.48% |
Mar 31, 2023 | 159.46B | -26.61B | -14.30% |
Mar 31, 2022 | 186.07B | 47.50B | 34.28% |
Mar 31, 2021 | 138.57B | 17.84B | 14.78% |
Mar 31, 2020 | 120.73B | 3.60B | 3.08% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |